SANA Q1 2023 Earnings — Sana Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

SANASana Biotechnology, Inc.

$900M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$84M

Net Income

-$82M

EPS (Diluted)

$-0.43

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$79M

Free Cash Flow

-$81M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$747M

Total Liabilities

$319M

Stockholders' Equity

$428M

Cash & Equivalents

$160M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$84M	-$32M	-165.3%
Net Income	-$82M	-$31M	-161.1%